Skip to main content
Back
Watch Compare

NRX Pharmaceuticals, Inc.

Data quality: 100%
Also listed as NRXPW Nasdaq
NRXP
Nasdaq Manufacturing Chemicals
$2.22
▼ $0.04 (-1.77%)
Mkt Cap: 74.73 M
Price
$2.26
Mkt Cap
74.73 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -14.11 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-2336.49%
Op. Margin-1324.41%

Safety

Debt / Equity
N/A
Current Ratio0.15
Interest Coverage-24.18

Valuation

PE (TTM|2027)
-2.61 | 0.58
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -2.6 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % -2336.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

4 analysts
Buy
Current
$2.22
+1611.7%
Target
$38.00
$25.00
$39.50
$48.00
Forecast
Forward P/E 0.56
Forward EPS $3.93
EPS Growth (est.) +2923.1%
Est. Revenue 537.97 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $3.93
$1.23 – $6.63
 537.97 M 2
FY2026 $0.13
$0.13 – $0.13
 110.09 M 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.08 $0.18 +329.1%
Q32025 -$0.02 -$0.51 -2938.4%
Q22025 -$0.23 -$0.98 -326.1%
Q12025 -$0.25 -$0.34 -36.0%

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
6.59% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.23 M Net Income (TTM) -28.62 M
ROE N/A ROA -783.95%
Gross Margin N/A Operating Margin -1324.41%
Net Margin -2336.49% Free Cash Flow (TTM) -14.11 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.15
Interest Coverage -24.18 Asset Turnover 0.34
Working Capital -18.56 M Tangible Book Value -23.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.61 Forward P/E N/A
P/B Ratio N/A P/S Ratio 61.01
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -18.88%
Market Cap 74.73 M Enterprise Value 73.29 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.04
FCF / Share -0.43 OCF / Share -0.43
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 49.30%
SBC-Adj. FCF -14.91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.23 M 0.0 — — —
Net Income -28.62 M -25.13 M -30.15 M -39.75 M -93.06 M
EPS (Diluted) — — — -0.60 -1.98
Gross Profit — — — — —
Operating Income -16.22 M -18.50 M -27.84 M -44.34 M -115.80 M
EBITDA — — — — —
R&D Expenses 3.78 M 6.20 M 13.37 M 17.03 M 20.26 M
SG&A Expenses 13.06 M — — — —
D&A 70,000.0 — — — —
Interest Expense 671,000.0 230,000.0 120,000.0 18,000.0 18,000.0
Income Tax 0.0 0.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.96 M 3.65 M 7.32 M 25.82 M 32.73 M
Total Liabilities 28.89 M 26.87 M 19.05 M 18.41 M 11.92 M
Shareholders' Equity -15.94 M -23.22 M -11.73 M 7.41 M 20.81 M
Total Debt — — 9.16 M — —
Cash & Equivalents 7.80 M 1.44 M 4.60 M 20.05 M —
Current Assets 8.89 M 3.30 M 6.88 M 25.80 M 32.71 M
Current Liabilities 28.58 M 21.86 M 19.05 M 15.59 M 11.92 M